Chilton Investment Company’s Eli Lilly LLY Stock Holding History

Chilton Investment Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.48M	Sell	5,963 -4,088	-41%	-$4.14M	0.13%	70
2025 Q4	$10.8M	Sell	10,051 -2,438	-20%	-$2.33M	0.23%	50
2025 Q3	$9.53M	Buy	12,489 +9,332	+296%	+$6.94M	0.19%	51
2025 Q2	$2.46M	Buy	3,157 +19	+0.6%	+$14.8K	0.05%	84
2025 Q1	$2.59M	Buy	3,138 +259	+9%	+$216K	0.06%	86
2024 Q4	$2.22M	Buy	2,879 +42	+1%	+$34.8K	0.06%	90
2024 Q3	$2.51M	Sell	2,837 -335	-11%	-$301K	0.07%	89
2024 Q2	$2.87M	Sell	3,172 -18	-0.6%	-$14.4K	0.08%	76
2024 Q1	$2.48M	Buy	3,190 +133	+4%	+$94.7K	0.07%	81
2023 Q4	$1.78M	Sell	3,057 -48	-2%	-$28K	0.05%	85
2023 Q3	$1.67M	Buy	3,105 +1,058	+52%	+$545K	0.05%	87
2023 Q2	$960K	Sell	2,047 -420	-17%	-$176K	0.03%	99
2023 Q1	$847K	Buy	+2,467	New	+$832K	0.03%	99
2016 Q1	–	Sell	-14,800	Closed	-$1.25M	–	132
2015 Q4	$1.25M	Hold	14,800	–	–	0.04%	91
2015 Q3	$1.24M	Hold	14,800	–	–	0.04%	113
2015 Q2	$1.24M	Buy	+14,800	New	+$1.13M	0.05%	111

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chilton Investment Company's LLY Position: Q1 2026 in Review

Chilton Investment Company reduced its Eli Lilly (LLY) stake by 41% in Q1 2026, selling an estimated $4.14M and leaving 5,963 shares worth $5.48M. The position accounts for 0.13% of the portfolio, ranked #70.

Chilton Investment Company first reported a position in LLY in Q2 2015 and has held it in 16 quarters since. The position peaked at $10.8M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Chilton Investment Company held 5,963 shares of Eli Lilly worth $5.48M as of Q1 2026.
Chilton Investment Company sold 4,088 Eli Lilly shares in Q1 2026, an estimated $4.14M.
Eli Lilly made up 0.13% of Chilton Investment Company's portfolio in Q1 2026, its #70 holding.
Chilton Investment Company first reported a position in Eli Lilly in Q2 2015 and has held it in 16 quarters since.
Chilton Investment Company's Eli Lilly position peaked at $10.8M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.